These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
855 related articles for article (PubMed ID: 32150664)
1. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma. Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma. Wang Q; Chen Q; Zhang X; Lu XL; Du Q; Zhu T; Zhang GY; Wang DS; Fan QM World J Gastroenterol; 2019 Sep; 25(36):5515-5529. PubMed ID: 31576097 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of the γ-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma. Wang G; Lu X; Du Q; Zhang G; Wang D; Wang Q; Guo X Sci Rep; 2020 Aug; 10(1):13519. PubMed ID: 32782270 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma. Hu J; Wang N; Yang Y; Ma L; Han R; Zhang W; Yan C; Zheng Y; Wang X BMC Gastroenterol; 2018 Dec; 18(1):186. PubMed ID: 30545306 [TBL] [Abstract][Full Text] [Related]
5. The Performance of Serum Alpha-Fetoprotein for Detecting Early-Stage Hepatocellular Carcinoma Is Influenced by Antiviral Therapy and Serum Aspartate Aminotransferase: A Study in a Large Cohort of Hepatitis B Virus-Infected Patients. Qian X; Liu Y; Wu F; Zhang S; Gong J; Nan Y; Hu B; Chen J; Zhao J; Chen X; Pan W; Dang S; Lu F Viruses; 2022 Jul; 14(8):. PubMed ID: 36016291 [TBL] [Abstract][Full Text] [Related]
6. Alpha-fetoprotein to transaminase ratio is related to higher diagnostic efficacy for hepatocellular carcinoma. Liu X; Meng J; Xu H; Niu J Medicine (Baltimore); 2019 Apr; 98(17):e15414. PubMed ID: 31027143 [TBL] [Abstract][Full Text] [Related]
7. [Clinical value of plasma scaffold protein SEC16A in evaluating hepatitis B-related liver cirrhosis and hepatocellular carcinoma]. Dong C; Chang CD; Zhao DD; Zhang XX; Guo PL; Dou Y; Zhao SX; Nan YM Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):621-626. PubMed ID: 37400387 [No Abstract] [Full Text] [Related]
8. A Novel Diagnostic Model for Early Hepatitis B Virus-Related Hepatocellular Carcinoma Diagnosis. Li S; Liu D; Wang Q Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649525 [TBL] [Abstract][Full Text] [Related]
9. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection. Song X; Wu A; Ding Z; Liang S; Zhang C Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467 [TBL] [Abstract][Full Text] [Related]
10. A comparison of clinical pathologic characteristics between alpha-fetoprotein negative and positive hepatocellular carcinoma patients from Eastern and Southern China. Chi X; Jiang L; Yuan Y; Huang X; Yang X; Hochwald S; Liu J; Huang H BMC Gastroenterol; 2022 Apr; 22(1):202. PubMed ID: 35461226 [TBL] [Abstract][Full Text] [Related]
11. Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer. Wan L; Guo L; Hu Y; Huang H; Zhang M; Xu K; De G; Zheng F; Wu Z; Hu C; Wen Z Clin Biochem; 2021 Mar; 89():44-50. PubMed ID: 33309517 [TBL] [Abstract][Full Text] [Related]
12. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection. Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288 [TBL] [Abstract][Full Text] [Related]
13. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma. Yao M; Zhao J; Lu F Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252 [TBL] [Abstract][Full Text] [Related]
14. A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B. Yang T; Xing H; Wang G; Wang N; Liu M; Yan C; Li H; Wei L; Li S; Fan Z; Shi M; Chen W; Cai S; Pawlik TM; Soh A; Beshiri A; Lau WY; Wu M; Zheng Y; Shen F Clin Chem; 2019 Dec; 65(12):1543-1553. PubMed ID: 31672853 [TBL] [Abstract][Full Text] [Related]
15. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II. Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134 [TBL] [Abstract][Full Text] [Related]
16. A novel prognostic score model based on combining systemic and hepatic inflammation markers in the prognosis of HBV-associated hepatocellular carcinoma patients. Zhang T; Liu Z; Zhao X; Mao Z; Bai L Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2246-2255. PubMed ID: 31169437 [No Abstract] [Full Text] [Related]
17. Combination of an Autoantibody Panel and Alpha-Fetoprotein for Early Detection of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Shen Y; Chen J; Wu J; Li T; Yi C; Wang K; Wang P; Sun C; Ye H Cancer Prev Res (Phila); 2024 May; 17(5):227-235. PubMed ID: 38489403 [TBL] [Abstract][Full Text] [Related]
18. Clinical implications of alpha-fetoprotein in chronic hepatitis C. Tai WC; Hu TH; Wang JH; Hung CH; Lu SN; Changchien CS; Lee CM J Formos Med Assoc; 2009 Mar; 108(3):210-8. PubMed ID: 19293036 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Serum GDF15, AFP, and PIVKA-II as Diagnostic Markers for HBV-Associated Hepatocellular Carcinoma. Chen J; Tang D; Xu C; Niu Z; Li H; Li Y; Zhang P Lab Med; 2021 Jul; 52(4):381-389. PubMed ID: 33159511 [TBL] [Abstract][Full Text] [Related]
20. On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir. Wong GL; Chan HL; Tse YK; Chan HY; Tse CH; Lo AO; Wong VW Hepatology; 2014 Mar; 59(3):986-95. PubMed ID: 24123097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]